The Need for systematic evaluations of diagnostic tests

Clinical Infectious Diseases

Volumn 51, Issue 5, 2010, Pages 609-610

  Jani, Ilesh V ^a  

^a INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 LYMPHOCYTE COUNT; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ANTI-HIV AGENTS; CLINICAL LABORATORY TECHNIQUES; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; HIV INFECTIONS; HUMANS; SOCIOECONOMIC FACTORS;

EID: 77955777574     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/655763     Document Type: Note

References (11)

1. Schünemann HJ, Oxman AD, Brozek J, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 2008; 336:1106-10.
2. Guyatt GH, Oxman AD, Vist GE, et al; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336:924-6.
3. Hutubessy RC, Baltussen RM, Torres-Edeier TT, Evans DB. Generalised cost-effectiveness analysis: an aid to decision making in health. Appl Health Econ Health Policy 2002; 1: 89-95.
4. Baltussen R. Priority setting of public spending in developing countries: do not try to do everything for everybody. Health Policy 2005; 78:149-56.
5. Guyatt GH, Oxman AD, Kunz R, et al; GRADE Working Group. Incorporating considerations of resources use into grading recommendations. BMJ 2008; 336: 1170-3.
6. Hogan DR, Baltussen R, Hayashi C, Lauer JA, Salomon JA. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. BMJ 2005; 331:1431-7.
7. Mugyenyi P, Walker AS, Hakim J, et al. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomized non-inferiority trial. Lancet 2010; 375:123-31.
8. Koenig SP, Schackman BR, Riviere C, et al. Clinical impact and cost of monitoring for asymptomatic laboratory abnormalities among patients receiving antiretroviral therapy in a resource-poor setting. Clin Infect Dis 2010; 51(5):600-608 (in this issue).
9. Canter JA, Robbins GK, Selph D, et al. African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapy. J Infect Dis 2010; 201:1703-7.
10. Li X, Breukers C, Ymeti A, et al. Clinical evaluation of a simple image cytometer for CD4 enumeration on HIV-infected patients. Cytometry B Clin Cytom 2010; 78:31-6.
11. Mine M, Bedi K, Maruta T, et al. .Q.uantitation of human immunodeficiency virus type 1 viral load in plasma using reverse transcriptase activity assay at a district hospital laboratory in Botswana: a decentralization pilot study. J Virol Methods 2009; 159:93-7.